A study of the effect of gender on interferon beta-1a (Avonex® 30 mcg) treatment in patients with multiple sclerosis

被引：0
|
作者：
Munschauer, FE
Herndon, R
Sandrock, AW
Tsao, E
Berkhoff, JE
Stubbendick, A
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Univ Mississippi, Jackson, MS 39216 USA
[3] Biogen Idec, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [21] Meningioma growth during interferon beta-1a treatment for multiple sclerosis
    Pinto Gama, Hugo Pereira
    da Rocha, Antonio Jose
    da Silva, Carlos Jorge
    Mendes, Maria Fernanda
    Veiga, Jose Carlos Esteves
    Lancellotti, Carmen Lucia Penteado
    Andrade, Victor Piana
    Tilbery, Charles Peter
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2008, 66 (2B) : 402 - 404
  • [22] Interferon beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran
    Kalanie, H
    Gharagozli, K
    Hemmatie, A
    Ghorbanie, M
    Kalanie, AR
    EUROPEAN NEUROLOGY, 2004, 52 (04) : 202 - 206
  • [23] Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a
    Pohl, D
    Rostasy, K
    Gärtner, J
    Hanefeld, F
    NEUROLOGY, 2005, 64 (05) : 888 - 890
  • [24] Cost effectiveness analysis of interferon beta-1a (Avonex®) in pre-clinically definite multiple sclerosis (CDMS)
    Iskedjian, M
    Walker, J
    Gray, T
    Vicente, C
    Einarson, T
    Gehshan, A
    VALUE IN HEALTH, 2004, 7 (03) : 290 - 290
  • [25] Retinopathy secondary to treatment with interferon beta-1a in a patient with multiple sclerosis
    Mallada-Frechín, J
    Abellin-Miralles, I
    Alfaro-Beltra, ML
    Medrano, V
    Muñoz-Gil, MB
    Fernández-Izquierdo, S
    Piqueras-Rodríguez, L
    REVISTA DE NEUROLOGIA, 2005, 40 (08) : 482 - 484
  • [26] Significance of serum neutralising antibodies to Avonex' (IFN beta-1a) in multiple sclerosis
    Rudick, RA
    Jones, W
    Alam, J
    Simonian, N
    Campion, M
    Jacobs, L
    Herndon, R
    Richert, J
    Salazar, A
    Cookfair, D
    Simon, J
    Coats, M
    Goodkin, D
    Mass, M
    NEUROLOGY, 1997, 48 (03) : 5003 - 5003
  • [27] The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis
    Leary, SM
    Thompson, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (03): : 508 - 509
  • [28] Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis
    不详
    FORMULARY, 2002, 37 (04) : 169 - 169
  • [29] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [30] Appropriate use of interferon beta-1a in multiple sclerosis
    Jacobs, L
    Brownscheidle, CM
    BIODRUGS, 1999, 11 (03) : 155 - 163
12345